Ecolab Inc., the global leader in water, hygiene and energy technologies and services, has launched Apex, a warewashing system that will provide the cleaning results restaurant and foodservice operators throughout Europe expect, while reducing water and energy use.
Covidien plc, a leading global provider of health care products and recognized innovator in patient monitoring and respiratory care devices, today announced the European commercial launch of its Nellcor™ Respiration Rate System. In addition to the Adult Respiratory Sensor, the system includes the Nellcor™ Respiration Rate Version 2.0 software and Nellcor™ Bedside Respiratory Patient Monitoring System, PM1000N, both of which recently received CE Mark approval.
Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced its Puritan Bennett™ 980 ventilator has received European Economic Area (EEA) CE Mark approval.
Covidien plc (NYSE: COV) today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and scope to serve a significant medical specialty, the multibillion dollar global gastrointestinal (GI) market.
Leading Forex & CFD broker AvaTrade has announced the launch of a new client promotion for 2014 aimed at experienced traders.
Dropbox, a free service that lets you bring your documents, photos and videos everywhere and share them easily, announced today that it will establish an office in Dublin, Ireland. The Dublin office will serve as the centre of the company’s international operations, enabling Dropbox to better provide technical support and product acumen to the millions of people across the world who use Dropbox to simplify their lives.
Cook Medical has received U.S. Food and Drug Administration (FDA) marketing approval for the first devices in its Zilver® PTX® Drug-Eluting Peripheral Stent portfolio, company officials reported today. It’s the first time the FDA has approved a drug-eluting stent to treat blockages in a peripheral artery.
Molson Coors Brewing Company (NYSE: TAP; TSX) today provided further
detail on its plans to incorporate the recently announced StarBev
acquisition into its business by naming Mark
Hunter CEO of the new business unit, which adds nine Central
European countries to its growth market portfolio. Hunter, who currently
serves as CEO of the company’s UK & Ireland business, is a 20-year
industry veteran with extensive experience in the European beer business.